Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia
Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...
Can cockroaches help us cure tularemia?
Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also...
Can personalized medicine subtype bladder cancer?
Molecular pathoepidemiology is the study of the cause and natural history of disease on a molecular, individual...